Final Results

Keystone Investment Trust plc Unaudited Preliminary Announcement of Final Results for the Year ended 30 September 2007 Chairman's Statement In the year to 30 September 2007, the Company's share price provided a total return of 11.1%. The total return of the net asset value per share was 10.0%. In the same period, the total return of the Company's benchmark for the purpose of performance measurement, the FTSE All-Share Total Return Index, was 12.2%. All these figures are with income reinvested. The discount of the share price relative to net asset value per share narrowed slightly from 11.6% at the end of September 2006 to 11.2% at 30 September 2007. Performance 6 months One Year Since appointment of current Manager on 1 January 2003 Share Price Total Return 2.6% 11.1% 173.6% NAV Total Return per share 0.8% 10.0% 144.9% FTSE All-Share Total Return 2.7% 12.2% 105.4% Index Source: Fundamental Data Gearing and investment guidelines The Company's borrowings, in the form of long-term debentures, amount to £40 million. At the year end £15.7 million was held in cash and certificates of deposit in order to keep the effective gearing to a level which the Board regards as sufficiently cautious. Equity exposure decreased during the year from 117% of net assets to 114%. The Board sets limits for this exposure and regularly reviews them. The present position is that the Manager must make no net purchases if equity exposure is more than 110% of net assets, and has to make sales if, as a result of market movements, equity exposure goes higher than 115% of net assets. It is up to the investment manager to decide on exposure subject to those limits. Up to £4 million may also be held in corporate bonds. During the year under review, no such bonds were held. Dividends The Company's objective is long-term growth of capital. The level of the Company's dividends is also important to many shareholders. The Board has declared a final dividend of 25p per share (2006: 21p), giving a total dividend for the year of 40p per share, compared with 35p last year. Earnings per share in this year were 41.6p (2006: 37.3p). The dividend will be paid on 21 December 2007 to shareholders on the Register on 23 November 2007. Expenses The Company's total management expenses were 1.0% of average net assets in the year ended 30 September 2007 (2006:1.0%, excluding performance fees in that year). The Manager During the year the Board again reviewed all aspects of the service provided by the Manager and the terms of the Manager's appointment. We remain satisfied with the service and the current terms of appointment. VAT on Management Fees In November this year, HM Revenue & Customs accepted the European Court of Justice ruling in a test case that investment trusts should not be charged VAT on management fees. This paves the way for the start of the process to recover VAT paid in the past on your Company's management fees. As you can appreciate, these fees span a number of years and the Board is holding discussions with the Manager concerning the amounts recoverable, and will advise shareholders of the results of these discussions in due course. Outlook After several years with returns in double figures, it is not all that surprising that for this reason alone markets have become more difficult, and there are plenty of economic and financial issues to worry about. We cannot expect double-figure returns in every year; nor can we expect the investment manager always to outperform the benchmark, the FTSE All-Share Index. We are, however, as confident as we were when we appointed Invesco Asset Management that we have in Mark Barnett an investment manager who, in the long term, will fulfil the Company's objectives: to provide, for the investor with the appropriate long-term outlook, strong returns from its portfolio of equities. Special Business at the Annual General Meeting (AGM) As special business of the AGM, the Board will ask shareholders to renew the Board's authority to allot up to an aggregate nominal amount of £334,219 new ordinary shares, this being 5% of the Company's issued ordinary share capital, whilst disapplying pre-emption rights. This authority, set out in Special Resolution 10, will expire at the AGM in 2008. Special Resolution 11 seeks the renewal the Board's authority to purchase up to 2,000,000 of the Company's own shares, this being 14.99% of the issued ordinary share capital. Again, this authority will expire at the AGM in 2008. Special Resolution 12 seeks to adopt revised Articles of Association for the Company. The Resolution concerns amendments to the Articles of Association of the Company, following the introduction of certain provisions of the Companies Act 2006, which came into force on 1 January, 20 January, 6 April and 1 October 2007, as well as the introduction of the Transparency Directive on 20 January 2007. Broadly, the proposed changes to the Articles of Association allow the Company to communicate with shareholders electronically via its website if it so chooses, unless a shareholder wishes to continue receiving information in hard copy; to remove the maximum age for Directors; and to change a number of references to statutory provisions in the Companies Act 1985 which have now been replaced by corresponding provisions in the Companies Act 2006. Further details are given in the Report of the Directors. Finally, pursuant to changes in UK Listing Rules, listed investment companies are now subject to additional requirements in respect of their published investment policies. To comply with the new standards, the Directors are proposing a restated investment policy to be formally adopted, subject to shareholders' approval of Ordinary Resolution 13 at the Annual General Meeting. The new, restated policy is set out in the Report of the Directors in the Annual Report and Accounts. This will not give rise to changes in the way the Company's assets are managed. The Directors have carefully considered all the resolutions proposed in the Notice to the Annual General Meeting and consider them all to be in the best interest of the Company and its shareholders. The Directors therefore recommend that shareholders vote in favour of each resolution. My fellow Directors and I look forward to seeing investors at the AGM of the Company on 20 December 2007, where there will be an opportunity to meet and question the investment manager. Richard Oldfield Chairman 19 November 2007 Manager's Report Market Review The UK equity market achieved a total return of +12.2% during the twelve months to 30 September 2007, as measured by the FTSE All Share Index. The overall return from UK equities is again very impressive, and marks the fifth successive year of double-digit gains. However, this year witnessed a substantial increase in volatility, which was particularly evident in the last 3 months of the period. Having started the period robustly with the FTSE All Share Index reaching new all-time highs in June, the market was hit by a serious bout of risk aversion towards the end of the period. This was caused by problems emanating from the US sub-prime mortgage market which severely undermined investor confidence. The potential for rising defaults on these assets was growing in the first half of the year but events this summer highlighted that the problems were much wider than the market had previously anticipated. In previous financial cycles, banks have been hit hardest by non-performing loans, but the recent appetite for innovative new financial instruments has allowed banks to package up these mortgage assets in new investment structures such as Collateralised Debt Obligations (CDOs), and sell them on to other investors, attracted by the high yield that these investments are able to generate. This has spread the risk of defaults across a very wide base of investors, many of whom it appears, were not fully aware of the risks associated with these new instruments. For some time, CDOs and other new financial structures had been viewed by the market as a positive development because of the risk diversification that they provided. Once defaults on the sub-prime mortgages held within these investments started to rise, the lack of transparency in the financial system led to a widespread risk aversion that affected all asset classes. Liquidity in credit markets dried up overnight, as investors quickly reappraised the risks of sub-prime loans and banks became reluctant to lend to each other. This so-called credit crunch was a very serious financial event, which ultimately led to the well-publicised downfall of Northern Rock. Unsurprisingly, the UK equity market suffered significant losses in July and August. Concerns that the financial crisis would spread to the wider economy prompted action from the Federal Reserve and European Central Bank, both of whom injected large amounts of money into the financial system. A further lifeline was thrown to the markets in mid-September in the form of a 0.5% cut in US interest rates from the Federal Reserve. Since that time, global equity markets have recovered all the mid-summer losses, with most major indices moving back up to new highs for the year. Portfolio Performance The Company's net asset value, including dividends, increased by +10.0% during the twelve months to the end of September 2007, compared to a total return of +12.2% from the FTSE All Share Index. The under-performance can be attributed largely to the defensive bias of the portfolio and a lack of exposure to both emerging market growth and merger & acquisition (M&A) speculation. In the first half, M&A activity, driven primarily by interest from private equity funds, was the source of a great deal of market speculation. Much of this activity, both rumoured and actual, has been focused on mid and small cap stocks which, in turn, drove out-performance from these areas compared to a more pedestrian performance from large caps. This trend worked against the Company in the first half of the year, as the portfolio has been increasingly focused towards the largest stocks in the market. The second half of the period under review has seen the first signs of a reversal of recent trends, in that large caps have enjoyed a spell of relative out-performance for the first time in many years. The portfolio's increased exposure to this part of the market was particularly rewarding in terms of performance during the summer volatility. Portfolio Strategy & Review The most important evolution to the strategy adopted for the portfolio over the last 18 months, has been a gradual move up the market cap scale to take advantage of opportunities amongst the very largest UK companies. Several years of underperformance have left many of these "mega-cap" stocks, as they are collectively known, trading at very attractive valuations. During the year, the Manager commenced positions in AstraZeneca and BP, and added to existing holdings in Vodafone, GlaxoSmithKline and Royal Dutch Shell. In terms of share price performance, the oil majors have not participated fully in the oil price rises we have seen in recent years. The last twelve months have been very disappointing in particular for BP, with problems at its Prudhoe Bay oilfield in Alaska and Texas City refinery weighing on sentiment. But the shares have also been overlooked by many investors simply because of the company's size - it is too big to benefit from M&A speculation and has therefore been easy for investors to ignore, or even to short, whilst in pursuit of the next bid target. The shares have looked increasingly attractive on valuation grounds and, with a new CEO in charge, the Manager believes the company will benefit from new thinking, with a strong emphasis towards shareholder returns. Royal Dutch Shell looks similarly attractive on most valuation measures and the Manager is confident that both stocks will contribute well to the portfolio going forward. Another area that has been broadly out of favour with the market for several years is the Pharmaceuticals sector. The Manager has held GlaxoSmithKline in the portfolio for some time and it continues to look significantly undervalued in his view. Indeed, he has added to the holding this year at times when the share price has been weak. The Manager has also bought AstraZeneca, whose share price has fallen substantially in recent months on concern about the company's lack of new drug candidates in the pipeline and the risk of patent expiries on key drugs. The recent acquisition of MedImmune in the US has not helped sentiment, being viewed by the market as over-priced. However, the Manager believes there is very sound long-term strategic sense in the MedImmune acquisition. The deal significantly expands the product pipeline and enhances the group's overall future growth prospects. Furthermore, the business fits well alongside last year's acquisition of Cambridge Antibody Technology and provides a strong exposure to a new area of potential drug development, namely biologicals, which is the use of more complex and effective drugs based on the human body's natural chemistry. The shares look significantly undervalued, with a considerably lower valuation now than at any stage in the company's history. At times, the M&A activity has been beneficial to the Company. Several stocks received bid approaches during the review period. Water company AWG was acquired by a consortium of private investors, realising a substantial profit for the portfolio. Lloyds insurer Wellington Underwriting was acquired by its larger rival Catlin, and ICI is in the process of being acquired by Akzo Nobel. As well as increasing the portfolio's exposure to the UK "mega-caps", the Manager added several other new holdings to the portfolio, including Marks & Spencer. Retailers have generally performed poorly in recent months as the market has started to discount the prospect of a significant consumer slowdown in the UK as we move into 2008. Whilst the Manager shares the market's concern regarding prospects for the UK consumer, he thinks Marks & Spencer offers some very attractive characteristics that will allow it to remain more resilient to a consumer slowdown than its peers. Over half of its sales are in food, an area of spend that is less cyclical and also currently benefiting from inflation. Meanwhile, Marks & Spencer's key customer group is the over-45's, where finances are generally in a better condition than amongst younger consumers. Marks & Spencer also displays "self-help" characteristics, with an ongoing store modernisation programme that is having an immediate and lasting impact on sales. The Manager believes these characteristics are not fully appreciated by the market and consequently the shares look very attractive for long-term returns. Rolls-Royce is another new holding for the portfolio. It is a very well-managed company, operating in markets that offer very attractive growth rates. The company has traditionally been viewed by the market as a cyclical manufacturer but, with over half of its revenues currently coming from long-term servicing contracts, it is not as cyclically vulnerable as it used to be. In the Manager's view, the valuation looks very attractive given the strength, stability and sustainability of the cashflows that the business is able to generate. Outlook The Manager's view of the economic outlook continues to be cautious. The Manager has felt for some time that the rate of consumer spending growth in the UK would have to moderate as a result of a very highly leveraged household balance sheet, and as the negative impact of higher interest rates filtered through to consumers' disposable income. The events of this summer in the credit markets are likely to leave a lasting impression in the form of higher borrowing costs and a more prudent approach from the banking sector towards risk across all forms of lending. This can only serve to exacerbate the slowdown in consumer activity. There are similar dynamics in the US, where ongoing problems in the US sub-prime mortgage market have already had a substantial impact on activity in the housing market, and caused the overall economy to slow. The situation in the UK differs in one important respect, however: the Bank of England will not cut interest rates until it has more confidence that medium-term inflation is under control. The Manager's prognosis for the UK economy is therefore bleak. But the market as a whole is aware of the challenges that the economy faces, and they are largely reflected in valuations. Some parts of the market, however, are much more vulnerable to the consumer slowdown, and the Manager continues to be wary of cyclical sectors such as banks, retailers and house-builders. Instead, the Manager continues to focus on companies that he believes will be able to continue to grow earnings and dividends, even in the more challenging economic environment that he foresees. In valuation terms, the UK "mega-caps" look more attractive now than they have done for a long time, and now form an important part of the portfolio. These are financially strong, highly liquid, globally diversified businesses, which offer further defensive characteristics. The Manager believes these characteristics are currently under-valued by the market as a whole, and should stand the Company in good stead going forward. Mark Barnett Investment Manager 19 November 2007 Income Statement For the year ended 30 September 2007 2006 Revenue Capital Total Revenue Capital Total £'000 £'000 £'000 £'000 £'000 £'000 Gain on investments - 14,045 14,045 - 26,355 26,355 Gain/(loss) on certificates of deposit - 22 22 - (27) (27) Foreign exchange gain/ - 1,011 1,011 - 753 753 (loss) Income 7,099 - 7,099 6,477 - 6,477 Investment management (368) (1,095) (1,463) (329) (2,118) (2,447) fees Other expenses (314) - (314) (295) - (295) Net return before finance costs and taxation 6,417 13,983 20,400 5,853 24,963 30,816 Finance costs (773) (2,279) (3,052) (771) (2,278) (3,049) Return on ordinary activities before tax 5,644 11,704 17,348 5,082 22,685 27,767 Tax on ordinary (78) - (78) (98) - (98) activities Return on ordinary activities after tax for the 5,566 11,704 17,270 4,984 22,685 27,669 financial year Return per ordinary share Basic 41.6p 8.8p 50.4p 37.3p 169.7p 207.0p The total column of this statement represents the Company's profit and loss account, prepared in accordance with UK Accounting Standards. The supplementary revenue and capital columns are both prepared under guidance published by the Association of Investment Companies. All items in the above statement derive from continuing operations and the Company has no other gains or losses. Therefore no statement of recognised gains or losses is presented. No operations were acquired or discontinued in the year. Reconciliation of movements in Shareholders' funds For the year ended 30 September Share Capital Capital Capital Share Premium Redemption Reserve- Reserve- Revenue Capital Account Reserve Realised Unrealised Reserve Total £'000 £'000 £'000 £'000 £'000 £'000 £'000 Balance as at 1 October 2005 6,685 1,258 466 96,164 32,791 6,051 143,415 Final dividend - - - - - (2,473) (2,473) for 2005 Net return on ordinary activities - - - 14,762 7,923 4,984 27,699 Interim dividend - - - - - (1,872) (1,872) paid in 2006 Balance as at 30 September 6,685 1,258 466 110,926 40,714 6,690 166,739 2006 Final dividend - - - - - (2,807) (2,807) for 2006 Net return on ordinary activities - - - 24,878 (13,174) 5,566 17,270 Interim dividend - - - - - (2,005) (2,005) paid 2007 Balance as at 30 September 6,685 1,258 466 135,804 27,540 7,444 179,197 2007 The accompanying notes are an integral part of those statements. Balance Sheet As at 30 September 2007 2006 £'000 £'000 Fixed assets Investments held as fair value through profit or loss 203,889 195,162 Current assets Certificates of deposit 5,004 9,970 Debtors 1,464 3,382 Cash and cash funds 10,713 1,950 17,181 15,302 Creditors: amounts falling due within one year (2,074) (3,126) Net current assets 15,107 12,176 Total assets less current liabilities 218,996 207,338 Creditors: amounts falling due after more than one year (39,799) (39,784) Provisions - (815) Net assets 179,197 166,739 Capital and reserves Share capital 6,685 6,685 Share premium account 1,258 1,258 Capital redemption reserve 466 466 Other reserves: Capital reserves - realised 135,804 110,926 Capital reserves - unrealised 27,540 40,714 Revenue reserve 7,444 6,690 Shareholders' funds 179,197 166,739 Net asset value per ordinary share Basic 1340.4p 1247.2p Cash flow statement For the year ended 30 September 2007 2006 £'000 £'000 Cash inflow from operating activities 4,679 2,694 Servicing of finance (3,036) (3,033) Capital expenditure and financial investment 11,008 (17,741) Equity dividends paid (4,812) (4,345) Net cash outflow before management of liquid resources and financing 7,839 (22,425) Management of liquid resources (8,750) 21,717 Decrease in cash (911) (708) Reconciliation of net cash flow to movement in net debt Decrease in cash (911) (708) Cashflow from movement in liquid resources 8,750 (21,717) Exchange movements 924 757 Debenture stock non-cash movement (15) (14) Movement in net debt in the year 8,748 (21,682) Net debt at beginning of year (37,834) (16,152) Net debt at end of year (29,086) (37,834) Notes to the Preliminary Announcement 1. Accounting policies The accounting policies adopted at 30 September 2006 have been applied consistently throughout the year. (a) Basis of Preparation The financial statements have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice ("UK GAAP") and with the Statement of Recommended Practice ("SORP") "Financial Statements of Investment Trust Companies", issued by the Association of Investment Companies in December 2005. 2. Income 2007 2006 £'000 £'000 Income from investments UK dividends 6,111 5,049 Overseas dividends 723 946 UK unfranked investment income - interest 263 386 7,097 6,381 Other income Deposit interest 1 96 Underwriting commission 1 - 2 96 Total income 7,099 6,477 3. Investment management fees 2007 2006 Revenue Capital Total Revenue Capital Total £'000 £'000 £'000 £'000 £'000 £'000 Investment management fee 313 940 1,253 280 839 1,119 Performance related fee relating to: 31 December 2005 - - - - 270 270 31 December 2006 - (7) (7) - - - Provision for performance related fee relating to: 31 December 2006 - - - - 693 693 31 December 2007 - - - - - - Irrecoverable VAT thereon 55 162 217 49 316 365 368 1,095 1,463 329 2,118 2,447 Details of the management agreement are disclosed in the Report of the Directors in the Annual Report and Accounts. Performance- related fees are based on a calendar year. No performance fee has been provided for the year ended 31 December 2007. The performance fee provision as at 30 September 2006 was £815,000 and the actual amount paid was £808,000 for the calendar year ended 31 December 2006 (31 December 2005: £1,214,000). 4. Return per ordinary share Basic revenue, capital and total return per ordinary share is based on each of the returns on ordinary activities after taxation and on 13,368,799 (2006: 13,368,799) shares being the number of shares in issue throughout the year. 5. Net asset value per ordinary share The net asset value per ordinary share and the net assets attributable at the year end were as follows: Net asset value Net assets Per share Attributable 2007 2006 2007 2006 pence pence £'000 £'000 Ordinary shares - Basic 1340.4p 1247.2p 179,197 166,739 Net asset value per ordinary share is based on net assets at the year end and on 13,368,799 (2006: 13,368,799) ordinary shares, being the number of ordinary shares in issue at the year end. 6. Notes to the cash flow statement (a) Reconciliation of operating profit to operating cash flows 2007 2006 £'000 £'000 Total return before finance costs and 20,400 30,816 taxation Adjustment for gains on investments and (14,067) (26,328) certificates of deposit Adjustment for exchange gains/losses (1,011) (753) Decrease/(increase) in debtors 200 (261) Decrease in creditors and provisions (765) (682) Tax on unfranked investment income (78) (98) Net cash inflow from operating activities 4,679 2,694 (b) Analysis of changes in net debt Debenture Stock 1 Cash Exchange Non-cash 30 October September 2006 Flow Movements Movement 2007 £'000 £'000 £'000 £'000 £'000 (Overdraft)/cash - (911) 924 - 13 Cash funds and 1,950 8,750 - - 10,700 short-term deposits Debentures (39,534) - - (15) (39,549) 5% Cumulative (250) - - - (250) preference shares Net debt (37,834) 7,839 924 (15) (29,086) The financial information set out above does not constitute the Company's statutory accounts for the year ended 30 September 2007 or 2006. The financial information for 2006 is derived from the statutory accounts for 2006 which have been delivered to the Registrar of Companies. The auditors have reported on the 2006 statutory accounts and their report was unqualified and did not contain a statement under s237(2) or (3) of the Companies Act 1985. The statutory accounts for 2007 will be finalised on the basis of the information presented by the Directors in this preliminary announcement and will be delivered to the Registrar of Companies following the Company's Annual General Meeting. The audited Annual Report and Accounts will be posted to shareholders shortly. Copies may be obtained during normal business hours from the Company's Registered Office, 30 Finsbury Square, London EC2A 1AG. A final dividend of 25p per share is recommended for payment on 21 December 2007 to shareholders on the register of members on 23 November 2007. The Annual General Meeting will be held at the Company's Registered Office on Thursday, 20 December 2007 at 11.00am. By order of the Board Invesco Asset Management Limited 19 November 2007
UK 100

Latest directors dealings